FSD Pharma Class Valuation
| HUGEDelisted Stock | USD 0.09 0 4.56% |
FSD Pharma seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of FSD Pharma Class from examining the firm fundamentals such as shares owned by insiders of 9.74 %, and Current Valuation of 4.57 M as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that FSD Pharma's price fluctuation is very steady at this time. Calculation of the real value of FSD Pharma Class is based on 3 months time horizon. Increasing FSD Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the FSD stock is determined by what a typical buyer is willing to pay for full or partial control of FSD Pharma Class. Since FSD Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of FSD Stock. However, FSD Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0899 | Real 0.0854 | Hype 0.09 |
The real value of FSD Stock, also known as its intrinsic value, is the underlying worth of FSD Pharma Class Company, which is reflected in its stock price. It is based on FSD Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of FSD Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of FSD Pharma Class helps investors to forecast how FSD stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of FSD Pharma more accurately as focusing exclusively on FSD Pharma's fundamentals will not take into account other important factors: FSD Pharma Total Value Analysis
FSD Pharma Class is currently forecasted to have valuation of 4.57 M with market capitalization of 4.65 M, debt of 337.46 K, and cash on hands of 31.62 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the FSD Pharma fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.57 M | 4.65 M | 337.46 K | 31.62 M |
FSD Pharma Asset Utilization
One of the ways to look at asset utilization of FSD is to check how much profit was generated for every dollar of assets it reports. FSD Pharma Class shows a negative utilization of assets of -0.34 percent, losing $0.003374 for each dollar of assets held by the firm. Inefficient asset utilization denotes the company is being less capable with each dollar of assets it shows. Put another way, asset utilization of FSD Pharma Class shows how inadequate it operates for each dollar spent on its assets.FSD Pharma Ownership Allocation
FSD Pharma holds a total of 46.06 Million outstanding shares. FSD Pharma Class shows 9.74 percent of its outstanding shares held by insiders and 2.81 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.FSD Pharma Profitability Analysis
Net Loss for the year was (18.56 M) with loss before overhead, payroll, taxes, and interest of (3.33 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates FSD Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in FSD Pharma and how it compares across the competition.
About FSD Pharma Valuation
The delisted stock valuation mechanism determines FSD Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of FSD Pharma. We calculate exposure to FSD Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of FSD Pharma's related companies.FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.
FSD Pharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as FSD Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 39.6 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in FSD Stock
If you are still planning to invest in FSD Pharma Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FSD Pharma's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |